Drug that keeps surface receptors on cancer cells makes them more visible to immune cells

A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/03/200305132210.htm